Press Releases
RDIF and Dr. Reddy’s to cooperate on clinical trials and supply of 100 million doses of Sputnik V vaccine to India
The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and Dr. Reddy’s Laboratories Ltd. (Dr. Reddy’s), a global pharmaceutical company headquartered out of India, have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in...
Packaging & Labelling
FedEx to Transform Package Tracking with SenseAware ID, the Latest Innovation in FedEx Sensor Technology
FedEx to Transform Package Tracking with SenseAware ID, the Latest Innovation in FedEx Sensor Technology SenseAwareID to Provide Enhanced Package Visibility for COVID-19 Vaccine and Other Critical Shipments MEMPHIS, Tenn, September 16, 2020—FedEx Corp. announced the launch of SenseAwareID,...
Press Releases
Merck expands BioReliance viral clearance offering in Singapore
Merck, a leading science and technology company, has announced an expansion of its Singapore biosafety testing laboratory services. These services allow customers to conduct viral clearance studies that ensure the safety and quality of their biological drugs during the...
Press Releases
TraceLink Announces Results from FDA DSCSA Pilot Program
TraceLink Inc., the leading digital platform company for the life science supply chain, today announced results from its pilot for the Food and Drug Administration (FDA) Pilot Project Program under the Drug Supply Chain Security Act (DSCSA).
The TraceLink pilot...
Press Releases
GigaGen Initiates Large-Scale Manufacturing of its First-in-Class Recombinant Hyperimmune Drug for COVID-19, GIGA-2050
GigaGen Inc., a biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and checkpoint resistant cancers, announced the company has initiated large-scale manufacturing of its first-in-class recombinant hyperimmune drug for COVID-19, GIGA-2050, in collaboration with two partners...
Clinical Trials
Takeda Announces Results from Phase 3 Clinical Trial Evaluating NINLARO in Newly Diagnosed Multiple Myeloma
Takeda Pharmaceutical Company Limited announced results from the Phase 3 TOURMALINE-MM2 trial evaluating the addition of NINLARO™ (ixazomib) to lenalidomide and dexamethasone versus lenalidomide and dexamethasone plus placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem...
Packaging & Labelling
Tjoapack invests in automated injectables packaging capabilities
Tjoapack is investing in its automated packaging capabilities to meet growing customer demand for pre-filled syringes and vials.
The automated packaging line for vials will start operations in Q1 2021 and will increase its capacity to over 12 million vials...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















